Vivos Therapeutics, Inc. (VVOS)
0.6646
-0.06
(-7.68%)
USD |
NASDAQ |
May 07, 16:00
0.6646
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics SG&A Expense (TTM) : 29.13M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Acurx Pharmaceuticals, Inc. | 6.230M |
| Celldex Therapeutics, Inc. | 43.84M |
| Plus Therapeutics, Inc. | 12.13M |
| Atossa Therapeutics, Inc. | 15.96M |
| Abeona Therapeutics, Inc. | 65.03M |